Recombination-mediated dissemination of Methicillin-resistant S. aureus clonal complex 1 in the Egyptian health care settings

Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) is a rapidly evolving pathogen that is frequently associated with outbreaks and sustained epidemics. This study investigated the population structure, resistome, virulome, and the correlation between antimicrobial resistance dete...

Full description

Saved in:
Bibliographic Details
Main Authors: Salma W. Elsayed (Author), Reem A. Elghaish (Author), Eman Badr (Author), Shaimaa F. Mouftah (Author), Nehal A. Saif (Author), Iman S. Naga (Author), Ahmed H. Shata (Author), Ben Pascoe (Author), Samuel K. Sheppard (Author), Mohamed Elhadidy (Author)
Format: Book
Published: BMC, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_45f663a8e8a84454bc4aa1b4c0b3f54d
042 |a dc 
100 1 0 |a Salma W. Elsayed  |e author 
700 1 0 |a Reem A. Elghaish  |e author 
700 1 0 |a Eman Badr  |e author 
700 1 0 |a Shaimaa F. Mouftah  |e author 
700 1 0 |a Nehal A. Saif  |e author 
700 1 0 |a Iman S. Naga  |e author 
700 1 0 |a Ahmed H. Shata  |e author 
700 1 0 |a Ben Pascoe  |e author 
700 1 0 |a Samuel K. Sheppard  |e author 
700 1 0 |a Mohamed Elhadidy  |e author 
245 0 0 |a Recombination-mediated dissemination of Methicillin-resistant S. aureus clonal complex 1 in the Egyptian health care settings 
260 |b BMC,   |c 2023-12-01T00:00:00Z. 
500 |a 10.1186/s12941-023-00659-y 
500 |a 1476-0711 
520 |a Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) is a rapidly evolving pathogen that is frequently associated with outbreaks and sustained epidemics. This study investigated the population structure, resistome, virulome, and the correlation between antimicrobial resistance determinants with phenotypic resistance profiles of 36 representative hospital-acquired MRSA isolates recovered from hospital settings in Egypt. Results The community-acquired MRSA lineage, clonal complex 1 (CC1) was the most frequently detected clone, followed by three other globally disseminated clones, CC121, CC8, and CC22. Most isolates carried SCCmec type V and more than half of isolates demonstrated multi-drug resistant phenotypes. Resistance to linezolid, a last resort antibiotic for treating multidrug resistant MRSA, was observed in 11.11% of the isolates belonging to different genetic backgrounds. Virulome analysis indicated that most isolates harboured a large pool of virulence factors and toxins. Genes encoding aureolysin, gamma hemolysins, and serine proteases were the most frequently detected virulence encoding genes. CC1 was observed to have a high pool of AMR resistance determinants including cfr, qacA, and qacB genes, which are involved in linezolid and quaternary ammonium compounds resistance, as well as high content of virulence-related genes, including both of the PVL toxin genes. Molecular clock analysis revealed that CC1 had the greatest frequency of recombination (compared to mutation) among the four major clones, supporting the role of horizontal gene transfer in modulating AMR and hypervirulence in this clone. Conclusions This pilot study provided evidence on the dissemination success of CA-MRSA clone CC1 among Egyptian hospitals. Co-detection of multiple AMR and virulence genes in this lineage pose a broad public health risk, with implications for successful treatment. The results of this study, together with other surveillance studies in Egypt, should be used to develop strategies for controlling MRSA infections in Egyptian health-care settings. 
546 |a EN 
690 |a Methicillin-resistant Staphylococcus aureus (MRSA) 
690 |a Hospital settings 
690 |a Antimicrobial resistance 
690 |a Virulence 
690 |a Recombination 
690 |a Linezolid resistance 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
690 |a Microbiology 
690 |a QR1-502 
655 7 |a article  |2 local 
786 0 |n Annals of Clinical Microbiology and Antimicrobials, Vol 22, Iss 1, Pp 1-14 (2023) 
787 0 |n https://doi.org/10.1186/s12941-023-00659-y 
787 0 |n https://doaj.org/toc/1476-0711 
856 4 1 |u https://doaj.org/article/45f663a8e8a84454bc4aa1b4c0b3f54d  |z Connect to this object online.